ESC Premium Access

Are NOACs really better than VKA in the real world?

Event: ESC Congress 2018
Topic: Cardiovascular Pharmacotherapy
Session type: Advances in Science
Date: 27 August 2018
Time: 16:45 - 17:45

Session

4 presentations in this session

Are NOACs really better than VKA in the real world? - Current knowledge

Speaker: Professor B. Lewis (Haifa, IL)
Thumbnail

Non-vitamin K oral anticoagulants in comparison to phenprocoumon in geriatric and non-geriatric patients: a retrospective, observational study on 71,000 patients with non-valvular atrial fibrillation

Speaker: Doctor C. Hohmann (Cologne, DE)
Thumbnail

Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol

Speaker: Doctor M. Esteve Pastor (Murcia, ES)
Thumbnail

Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients presenting myocardial infarction with percutaneous coronary intervention

Speaker: Associate Professor K. Lee (Gwangju, KR)
Thumbnail

4 speakers from this session

Professor Basil S Lewis

Lady Davis Carmel Medical Center, Haifa (Israel)
1 presentation
0 follower

Doctor Christopher Hohmann

Cologne University Hospital - Heart Center, Cologne (Germany)
0 follower

Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
0 follower

Associate Professor Ki Hong Lee

Chonnam National University Hospital, Gwangju (Korea (Republic of))
0 follower

This platform is supported by

logo Novo Nordisk